The New York Times' March 2026 coverage outlines a familiar libertarian argument: several states are advancing legislation to expand legal sales of unpasteurized milk, with MAHA-aligned advocates asserting that adults should have the right to choose what they consume. While the piece correctly notes the risk rhetoric from public health officials, it underplays the scale and consistency of the evidence base and fails to connect this trend to broader patterns of institutional distrust amplified since the COVID-19 pandemic.

CDC national surveillance data (observational, passive reporting system covering the entire U.S. population from 1993–2012, later updated through 2020 MMWR reports) documented 127 outbreaks linked to raw milk or raw-milk products, resulting in 1,909 illnesses, 230 hospitalizations, and two deaths. These figures come from outbreak investigations rather than RCTs, which would be unethical to conduct for known pathogens. A 2018 systematic analysis published in the Journal of Food Protection (review of 17 years of state data) identified 202 outbreaks causing over 2,600 illnesses, with Campylobacter, Salmonella, and Shiga toxin-producing E. coli as primary agents. Hospitalization rates were notably higher than those associated with pasteurized dairy. The NYT article mentions risk but does not quantify these numbers or note that children under 5 and immunocompromised individuals bear disproportionate burden.

Proponents claim nutritional superiority and allergy prevention. These assertions largely rest on observational studies with confounding variables. The European PASTURE cohort (approximately 1,000 children, longitudinal observational, published in Journal of Allergy and Clinical Immunology) found an association between raw farm milk consumption and reduced asthma/atopy rates; however, researchers explicitly noted confounding by farm microbial exposure and emphasized that results cannot be causally attributed to the milk itself. No large, well-controlled RCTs support these benefits, and a 2022 Frontiers in Microbiology systematic review concluded that any potential immunological upside is outweighed by infection risks.

What the original coverage missed is the political pattern: MAHA's raw-milk push mirrors its stances on vaccine skepticism and ultra-processed food avoidance. This represents a post-trust reframing of public health—where regulatory agencies like the FDA (which banned interstate raw milk sales in 1987 following multiple outbreaks) are cast as overreaching, and 'natural' consumption becomes an act of resistance. Similar dynamics appeared in COVID-era resistance to masking and school closures. The freedom-to-choose framing ignores negative externalities: outbreaks often require significant public resources for contact tracing and medical care, effectively socializing the costs of individual decisions.

Synthesizing the NYT reporting with CDC surveillance and peer-reviewed syntheses reveals a classic tension. Personal liberty remains a core value, yet evidence from large-scale epidemiological monitoring shows raw milk consistently carries measurable, preventable harm. States expanding access without mandatory testing, clear labeling of risks, or exclusion for high-risk groups may be prioritizing ideology over the precautionary principle that has guided dairy safety for a century. The debate ultimately asks whether health policy should be governed by the best available observational and microbiological data or by consumer autonomy amplified through political movements.